Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic-Reference-Cited by-同舟云学术

Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic

Published:2022-04-18 Issue:Supplement_1 Volume:75 Page:S5-S10
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Sherman Amy C¹²^ORCID,Rouphael Nadine³,Baden Lindsey R¹

Affiliation:

1. Division of Infectious Diseases, Brigham and Women’s Hospital and Harvard Medical School , Boston, Massachusetts , USA

2. Precision Vaccines Program, Division of Infectious Diseases, Boston Children’s Hospital , Boston, Massachusetts , USA

3. Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University , Atlanta, Georgia , USA

Abstract

Abstract Vaccine clinical trials have been essential to developing effective severe acute respiratory syndrome coronavirus 2 vaccines. The challenges of supply chain disruptions, infection control, study designs, and participant factors that affect trial procedures are reviewed, with specific solutions to streamline the clinical trial process.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac301/43391719/ciac301.pdf

Reference24 articles.

1. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study;Gouglas;Lancet Global Health,2018

2. Risk in vaccine research and development quantified;Pronker;PLoS One,2013

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020